应收账款坏账准备转回
Search documents
江苏硕世生物科技股份有限公司关于部分应收账款坏账准备转回的公告
Shang Hai Zheng Quan Bao· 2026-01-18 18:44
Group 1 - The company has reached an agreement with its debtor, Urumqi Rongxin Kanda Trading Co., Ltd., to settle outstanding accounts receivable amounting to RMB 609.94 million, which is part of a total receivable of RMB 692.05 million that has aged over five years [2][3] - The debtor is required to make the payment by January 20, 2026, and failure to do so will allow the company to claim the original debt amount along with a 20% penalty and all costs incurred in recovering the debt [2] - The recovery of this accounts receivable and the reversal of the corresponding bad debt provision is expected to positively impact the company's financial condition and operating results for the year 2026, with the exact impact to be confirmed by the annual audit [4] Group 2 - The company has fully settled the debt relationship with the debtor as of the announcement date, confirming that the payment of RMB 609.94 million has been received in full [3] - The reversal of the bad debt provision adheres to the relevant accounting standards and regulations, ensuring that it does not harm the interests of the company and its shareholders [4]